Vanguard Group’s Salarius Pharmaceuticals SLRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,563
| Closed | -$7.7K | – | 4440 |
|
|
2024
Q1 | $7.7K | Hold |
14,563
| – | – | ﹤0.01% | 4434 |
|
|
2023
Q4 | $9.47K | Buy |
14,563
+300
| +2% | +$195 | ﹤0.01% | 4480 |
|
|
2023
Q3 | $9.38K | Sell |
14,263
-700
| -5% | -$461 | ﹤0.01% | 4523 |
|
|
2023
Q2 | $22.3K | Sell |
14,963
-457
| -3% | -$681 | ﹤0.01% | 4511 |
|
|
2023
Q1 | $29.5K | Sell |
15,420
-22,734
| -60% | -$43.4K | ﹤0.01% | 4509 |
|
|
2022
Q4 | $58.4K | Sell |
38,154
-1,315,219
| -97% | -$2.01M | ﹤0.01% | 4430 |
|
|
2022
Q3 | $264K | Sell |
1,353,373
-231,647
| -15% | -$45.2K | ﹤0.01% | 4375 |
|
|
2022
Q2 | $333K | Hold |
1,585,020
| – | – | ﹤0.01% | 4380 |
|
|
2022
Q1 | $631K | Hold |
1,585,020
| – | – | ﹤0.01% | 4337 |
|
|
2021
Q4 | $785K | Hold |
1,585,020
| – | – | ﹤0.01% | 4332 |
|
|
2021
Q3 | $1.62M | Buy |
1,585,020
+40,296
| +3% | +$41.1K | ﹤0.01% | 4125 |
|
|
2021
Q2 | $1.64M | Buy |
1,544,724
+124,192
| +9% | +$132K | ﹤0.01% | 4026 |
|
|
2021
Q1 | $2.1M | Buy |
1,420,532
+1,324,231
| +1,375% | +$1.96M | ﹤0.01% | 3850 |
|
|
2020
Q4 | $88K | Buy |
96,301
+57,825
| +150% | +$52.8K | ﹤0.01% | 4152 |
|
|
2020
Q3 | $32K | Buy |
+38,476
| New | +$32K | ﹤0.01% | 4085 |
|
|
2019
Q3 | – | Sell |
-119,407
| Closed | -$66K | – | 4164 |
|
|
2019
Q2 | $66K | Hold |
119,407
| – | – | ﹤0.01% | 4083 |
|
|
2019
Q1 | $46K | Hold |
119,407
| – | – | ﹤0.01% | 4067 |
|
|
2018
Q4 | $39K | Sell |
119,407
-109,654
| -48% | -$35.8K | ﹤0.01% | 4091 |
|
|
2018
Q3 | $106K | Sell |
229,061
-111,643
| -33% | -$51.7K | ﹤0.01% | 4067 |
|
|
2018
Q2 | $321K | Buy |
340,704
+9,628
| +3% | +$9.07K | ﹤0.01% | 3906 |
|
|
2018
Q1 | $1.66M | Buy |
331,076
+23,632
| +8% | +$118K | ﹤0.01% | 3525 |
|
|
2017
Q4 | $1.07M | Buy |
307,444
+36,181
| +13% | +$126K | ﹤0.01% | 3598 |
|
|
2017
Q3 | $925K | Buy |
271,263
+6,365
| +2% | +$21.7K | ﹤0.01% | 3611 |
|
|
2017
Q2 | $1.02M | Sell |
264,898
-52,337
| -16% | -$202K | ﹤0.01% | 3562 |
|
|
2017
Q1 | $1.4M | Buy |
317,235
+5,154
| +2% | +$22.7K | ﹤0.01% | 3495 |
|
|
2016
Q4 | $1.65M | Sell |
312,081
-34,325
| -10% | -$181K | ﹤0.01% | 3420 |
|
|
2016
Q3 | $4.08M | Buy |
346,406
+2,545
| +0.7% | +$30K | ﹤0.01% | 3108 |
|
|
2016
Q2 | $3.51M | Buy |
343,861
+39,243
| +13% | +$401K | ﹤0.01% | 3147 |
|
|
2016
Q1 | $3.34M | Buy |
304,618
+79,866
| +36% | +$876K | ﹤0.01% | 3162 |
|
|
2015
Q4 | $2.8M | Buy |
224,752
+47,751
| +27% | +$594K | ﹤0.01% | 3264 |
|
|
2015
Q3 | $2.13M | Buy |
177,001
+16,027
| +10% | +$193K | ﹤0.01% | 3352 |
|
|
2015
Q2 | $2.77M | Buy |
160,974
+9,611
| +6% | +$165K | ﹤0.01% | 3287 |
|
|
2015
Q1 | $2.97M | Buy |
+151,363
| New | +$2.97M | ﹤0.01% | 3240 |
|